Related Experiment Videos
Vancomycin: conformational consequences of the sugar substituent
S G Grdadolnik1, P Pristovsek, D F Mierke
1National Institute of Chemistry, Hajdrihova 19, 1001 Ljubljana, Slovenia.
Journal of Medicinal Chemistry
|June 17, 1998
Summary
High-resolution structures reveal vancomycin has two main conformations, while aglyco-vancomycin has one. This structural difference, influenced by glycosylation, may impact antibiotic activity.
Area of Science:
- Structural biology
- Medicinal chemistry
- Computational chemistry
Background:
- Vancomycin is a critical antibiotic for treating Gram-positive bacterial infections.
- Understanding vancomycin's structure-activity relationship is crucial for developing new antibiotics.
- Glycosylation is a key modification in many natural products with biological activity.
Purpose of the Study:
- To determine the high-resolution three-dimensional structures of vancomycin and aglyco-vancomycin in solution.
- To investigate the conformational flexibility and dynamics of these molecules.
- To elucidate the role of glycosylation in vancomycin's structure and potential activity.
Main Methods:
- Nuclear magnetic resonance (NMR) spectroscopy was used to obtain experimental data.
- Metric matrix distance geometry and molecular dynamics calculations were employed for structure determination.
- Ensemble-based calculations analyzed conformational flexibility on the NMR time scale.
Main Results:
- Two distinct conformational families were identified for vancomycin, differing in vancosamine substituent positioning.
- Aglyco-vancomycin adopted a single, stable conformation in solution.
- Differences in amide proton alignment and aromatic ring orientation were observed between vancomycin and aglyco-vancomycin.
Conclusions:
- High-resolution structural characterization reveals significant conformational differences between vancomycin and its deglycosylated form.
- These structural variations, particularly in the glycosylation pattern, may play a role in vancomycin's antibiotic efficacy.
- The findings provide insights into the molecular basis of vancomycin's interaction with bacterial cell-wall precursors.